Book an appointment

🇦🇺 From Australia · Hepatology · Infectious disease

Hepatitis B treatment in China for Australia patients

End-to-end pathway: visa, flight, hospital match, cost and length of stay — tailored for patients travelling from Australia for hepatitis b care.

← Full Hepatitis B guide

Pathway at a glance

Visa
M-Visa (Medical Visa)
Processing
5–10 business days
Flight
10–12 hours (SYD/MEL to PEK/PVG)
Time zone
2–3 hours behind (Sydney) — same day arrival possible
Language
Strong English at all major Class A international departments

About hepatitis b

Chronic hepatitis B (CHB) affects approximately 296 million people globally per WHO estimates and remains one of the leading causes of cirrhosis and hepatocellular carcinoma. Modern nucleos(t)ide analogue therapy — entecavir, tenofovir disoproxil (TDF), and tenofovir alafenamide (TAF) — suppresses HBV DNA to undetectable in over 95% of treatment-naive patients, dramatically reducing long-term liver and cancer risk.

The barrier outside Class A Chinese care is rarely the medicine itself. It is the price. China has the most economical access to modern HBV antiviral therapy globally, with structured hepatology infrastructure to support both initial workup and long-term monitoring.

Why Australia patients travel to China

Australian patients commonly come for: orthopedic surgery (Medicare elective wait), stem cell therapy (TGA-restricted at home), cancer treatment (CAR-T, proton), dental tourism, and high-end executive physicals. Direct flights from major cities to Beijing/Shanghai.

Recommended cities for Australia patients

Shanghai (cardiology, orthopedic, oncology) and Beijing (PUMC) for major cases. Hong Kong / Shenzhen route popular for stem cell, dental and shorter trips.

Diagnostic workup at Class A centres

  • HBsAg + anti-HBs + anti-HBc (initial 3-marker panel)
  • If HBsAg positive: HBeAg + anti-HBe, HBV DNA quantitation
  • ALT, AST, GGT, complete metabolic panel, alpha-fetoprotein (HCC screening)
  • Abdominal ultrasound + FibroScan transient elastography for fibrosis staging
  • Hepatology consultation with structured treatment plan

Workup cost band: $200–$340 USD.

Treatment options

Tenofovir alafenamide (TAF / Vemlidy)

first-line

Modern oral antiviral with excellent bone and renal safety profile. China price: USD 15–30/month vs USD 1,400–1,800/month US.

Learn more →

Tenofovir disoproxil (TDF, generic)

first-line

Long-established first-line option. Generic available widely. China price: USD 5–15/month.

Learn more →

Entecavir (generic)

first-line

Alternative first-line nucleoside analogue. China price: USD 8–20/month.

Pegylated interferon alfa-2a

selected cases

Finite 48-week course; appropriate for selected HBeAg-positive patients with elevated ALT and low HBV DNA. Higher rate of HBsAg loss but more side effects than oral antivirals.

Liver transplant

advanced disease

Indicated for decompensated cirrhosis or HCC within criteria. Tianjin First Center, Renji, and major Beijing centres run high-volume programmes.

Learn more →

Visa pathway for Australia patients

Long Medicare wait times for elective surgery (knee/hip replacement, cataract) drive substantial Australian medical tourism to China. AUD purchasing power is favourable.

  1. 1

    Receive invitation letter

    Panda Touring Care issues hospital invitation letter within 3–5 business days.

  2. 2

    Complete COVA online

    Fill at cova.cs.mfa.gov.cn. Print and sign.

  3. 3

    Submit at CVASC

    Canberra, Sydney, Melbourne, Brisbane, or Perth visa centre with biometrics.

  4. 4

    Collect visa

    5–10 business days standard. Express 2–3 days.

Full Australia → China visa guide →

Frequently asked

Do Australia patients need a visa for hepatitis b treatment in China?
Yes — Australia citizens require M-Visa for medical treatment in China. Processing: 5–10 business days. Fee: AUD $109.50 standard · +AUD $80 expedited. Validity: Up to 3 years multi-entry possible.
How long is the flight from Australia to China?
10–12 hours (SYD/MEL to PEK/PVG)
Which Chinese cities are best for Australia patients seeking hepatitis b care?
Shanghai (cardiology, orthopedic, oncology) and Beijing (PUMC) for major cases. Hong Kong / Shenzhen route popular for stem cell, dental and shorter trips.
What's the diagnostic workup for hepatitis b at Class A international departments?
HBsAg + anti-HBs + anti-HBc (initial 3-marker panel); If HBsAg positive: HBeAg + anti-HBe, HBV DNA quantitation; ALT, AST, GGT, complete metabolic panel, alpha-fetoprotein (HCC screening); Abdominal ultrasound + FibroScan transient elastography for fibrosis staging; Hepatology consultation with structured treatment plan.

Plan your hepatitis b treatment from Australia

We arrange visa support, hospital match, written quote and door-to-door logistics from Australia. No obligation.

Request a quote Visa details